about
Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhageSmart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurologyNational Athletic Trainers' Association position statement: anabolic-androgenic steroids.The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports.Biological, Psychological, and Sociocultural Factors Contributing to the Drive for Muscularity in Weight-Training Men.Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Influence of Parent-Adolescent Communication About Anabolic Steroids on Adolescent Athletes' Willingness to Try Performance-Enhancing Substances.Moral disengagement and associated processes in performance-enhancing drug use: a national qualitative investigation.Athletes' perceptions toward substance use in Baghdad city.Tendon structural adaptations to load exercise are inhibited by anabolic androgenic steroids.Epidemiology of weight training-related injuries presenting to United States emergency departments, 1990 to 2007.Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.Effects of testosterone enanthate treatment in conjunction with resistance training on thyroid hormones and lipid profile in male Wistar rats.Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders.Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes’ FertilityValidation of a GC/MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis
P2860
Q24647601-AE9B028E-710E-4F44-89C1-D1F35C5B9F53Q28085743-D1A23A02-E975-4BD3-A51C-EEAD0E7CA479Q36299949-5EDBAF9D-E051-4ECA-A2A9-415044148494Q37033973-F6C09AF2-1F07-4B25-835E-FE8EDCB7F938Q37521338-5732B6BA-5D3A-4C0D-83CB-E990E834002CQ37724173-F1E50182-AB5A-4650-96A3-44603F908D25Q38589015-673F5C24-EC2A-41E7-A835-8B6BC7F8971BQ41513980-ED7DCD8F-6F0D-4C7D-9270-64E301D2A20EQ44261918-AC81697E-0D99-43FA-B0D5-5B53B1FF01AEQ46087058-8691554F-8C33-4F94-B1DE-48168CFF68CBQ46148782-6AE62F57-0DA0-497B-83CF-A270615B4635Q47446370-B4256EDF-AC5E-4F03-A8A7-C69C3B271E81Q47992683-393B54C7-5D81-4681-BF36-1AF13EF97977Q48360011-535B473E-4528-435B-9699-D1AAFB16EF2CQ50289113-1425C29E-CB00-4AA8-AE38-9AC01E8F371FQ56554879-49D97589-48E1-445F-93FC-3168CE700720Q57812287-78639855-11CC-4672-A2D8-9378AB0F9D6E
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Consequences of use of anabolic androgenic steroids.
@ast
Consequences of use of anabolic androgenic steroids.
@en
Consequences of use of anabolic androgenic steroids.
@nl
type
label
Consequences of use of anabolic androgenic steroids.
@ast
Consequences of use of anabolic androgenic steroids.
@en
Consequences of use of anabolic androgenic steroids.
@nl
prefLabel
Consequences of use of anabolic androgenic steroids.
@ast
Consequences of use of anabolic androgenic steroids.
@en
Consequences of use of anabolic androgenic steroids.
@nl
P2093
P1476
Consequences of use of anabolic androgenic steroids.
@en
P2093
Andrew Yates
Jill Griffith
Kathleen Blake
LaRae M Copley
Marcel J Casavant
P304
P356
10.1016/J.PCL.2007.04.001
P577
2007-08-01T00:00:00Z